BOCCHIA, MONICA
BOCCHIA, MONICA
Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin
2020-01-01 Gozzetti, Alessandro; Sammartano, Vincenzo; Bacchiarri, Francesca; Raspadori, Donatella; Bocchia, Monica
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma
2023-01-01 Sammartano, Vincenzo; Santoni, Adele; Zappone, Elisabetta; Calzoni, Paola; Fineschi, Daniela; Franceschini, Eleonora; Caroni, Federico; Sicuranza, Anna; Bocchia, Monica; Puccetti, Luca
A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia.
2004-01-01 Gozzetti, A; Tozzuoli, D; Crupi, R; Bocchia, Monica; Mazzotta, S; Raspadori, D; Lauria, Francesco
A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): A case report.
2011-01-01 Gozzetti, A; Cerase, A; Crupi, R; Raspadori, D; Defina, M; Bocchia, Monica; Lauria, Francesco
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2
2010-01-01 Gozzetti, A; Crupi, R; Rondoni, M; Defina, M; Bocchia, Monica; Pietrini, A; Raspadori, D; Lauria, Francesco
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid?
2021-01-01 Puccetti, Luca; Bacchiarri, Francesca; Calzoni, Paola; Santoni, Adele; Bocchia, Monica
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis
2021-01-01 Vanni, Francesca; Lopresti, Ludovica; Zurli, Vanessa; Kabanova, Anna; Cattaneo, Francesca; Sicuranza, Anna; Gozzetti, Alessandro; Gemma, Sandra; Zisterer, Daniela M; Bocchia, Monica; Campiani, Giuseppe; Baldari, Cosima T; Butini, Stefania; Ulivieri, Cristina
A novel t(6;7)(p24;q21) in a chronic myelocytic leuckemia in complete cytogenetic remission after therapy with imatinib mesylate.
2004-01-01 Gozzetti, A; Tozzuoli, D; Crupi, R; Fanelli, A; Gentili, S; Bocchia, Monica; Mazzotta, S; Raspadori, D; Lauria, F.
A P210-derived multipeptide vaccine (CMLVAX100) induces reduction of “stable” minimal residual disease in chronic myeloid leukemia (CML) patients during treatment with Imatinib or alpha-Interferon
2003-01-01 Bocchia, Monica; Gentili, S; Abruzzese, E; Fanelli, A; Iuliano, F; Tabilio, A; Forconi, Francesco; Gozzetti, A; Raspadori, D; Amabile, M; Lauria, Francesco
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation
2020-01-01 Dragani, Matteo; Rege Cambrin, Giovanna; Berchialla, Paola; Dogliotti, Irene; Rosti, Gianantonio; Castagnetti, Fausto; Capodanno, Isabella; Martino, Bruno; Cerrano, Marco; Ferrero, Dario; Gambacorti-Passerini, Carlo; Crugnola, Monica; Elena, Chiara; Breccia, Massimo; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Gozzini, Antonella; Bocchia, Monica; Lunghi, Francesca; Cedrone, Michele; Sgherza, Nicola; Luciano, Luigia; Russo, Sabina; Santoro, Marco; Giai, Valentina; Caocci, Giovanni; Levato, Luciano; Abruzzese, Elisabetta; Sora, Federica; Saglio, Giuseppe; Fava, Carmen
A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA: RETROSPECTIVE ANALYSIS OF 530 PATIENTS.
2011-01-01 Malagola, M; Skert, C; Vignetti, M; Piciocchi, A; G., Martinelli; Alimena, G; Mecucci, C; Testoni, N; Iacobucci, I; Clavio, M; Gobbi, M; Candoni, M; Damiani, D; Bocchia, Monica; Lauria, F; Zaccaria, A; Mazza, P; Visani, G; Peli, A; Colombi, C; Cancelli, V; Mancini, M; Fo, R; Martelli, M; Cantore, N; Raimondo, Fd; Petrini, M; DE FABRITIIS, P; Fioritoni, G; Nobile, F; Fabbiano, F; Specchia, G; Baccarani, G; LO COCO, F; Amadori, S; Mandelli, F; AND RUSSO, D.
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation
2016-01-01 Mazzei, MARIA ANTONIETTA; Bettini, Gloria; Pozzessere, Chiara; Guerrini, Susanna; Defina, Marzia; Ambrosio, MARIA RAFFAELLA; Aprile, Lara; Bocchia, Monica; Volterrani, Luca
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: A study by the GIMEMA working party on chronic myeloid leukemia
2005-01-01 Soverini, Simona; Martinelli, Giovanni; Rosti, Gianantonio; Bassi, Simona; Amabile, Marilina; Poerio, Angela; Giannini, Barbara; Trabacchi, Elena; Castagnetti, Fausto; Testoni, Nicoletta; Luatti, Simona; De Vivo, Antonio; Cilloni, Daniela; Izzo, Barbara; Fava, Milena; Abruzzese, Elisabetta; Alberti, Daniele; Pane, Fabrizio; Saglio, Giuseppe; Baccarani, Michele; GIMEMA CML Working, Party; Bocchia, Monica
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients
2006-01-01 Iacobucci, Ilaria; Saglio, Giuseppe; Rosti, Gianantonio; Testoni, Nicoletta; Pane, Fabrizio; Amabile, Marilina; Poerio, Angela; Soverini, Simona; Bassi, Simona; Cilloni, Daniela; Bassan, Renato; Breccia, Massimo; Lauria, Francesco; Izzo, Barbara; Merante, Serena; Frassoni, Francesco; Paolini, Stefania; Montefusco, Enrico; Baccarani, Michele; Martinelli, Giovanni; GIMEMA CML Working, Party; Bocchia, Monica
Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis
2012-01-01 Luatti, Simona; Castagnetti, Fausto; Marzocchi, Giulia; Baldazzi, Carmen; Gugliotta, Gabriele; Iacobucci, Ilaria; Specchia, Giorgina; Zanatta, Lucia; Rege Cambrin, Giovanna; Mancini, Marco; Abruzzese, Elisabetta; Zaccaria, Alfonso; Grimoldi, Maria Grazia; Gozzetti, Alessandro; Ameli, Gaia; Capucci, Maria Adele; Palka, Giandomenico; Bernasconi, Paolo; Palandri, Francesca; Pane, Fabrizio; Saglio, Giuseppe; Martinelli, Giovanni; Rosti, Gianantonio; Baccarani, Michele; Testoni, Nicoletta; GIMEMA CML Working, Party; Bocchia, Monica
Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients
2015-01-01 Breccia, Massimo; Efficace, Fabio; Sica, Simona; Abruzzese, Elisabetta; Cedrone, Michele; Turri, Diamante; Gobbi, Marco; Carella, Angelo Michele; Gozzini, Antonella; Usala, Emilio; Cavazzini, Francesco; Danise, Paolo; Tiribelli, Mario; Binotto, Gianni; Pregno, Patrizia; Bocchia, Monica; Gaidano, Gianluca; Crugnola, Monica; Bonifacio, Massimiliano; Avanzini, Paolo; Celesti, Francesca; Guella, Anna; Martino, Bruno; Annunziata, Mario; Luciano, Luigiana; Stagno, Fabio; Vallisa, Daniele; Pungolino, Esther; Iurlo, Alessandra; Rambaldi, Alessandro; Nardiello, Ida; Orlandi, Esther; Gambacorti Passerini, Carlo; Alimena, Giuliana
Alpha-2b recombinant interferon (Intron) in Hodgkins' lymphoma: Therapeutic perspective.
1990-01-01 Mazza, P; Tura, S; Bocchia, Monica; Zinzani, Pl; Gherlinzoni, F; Mandelli, F; Anselmo, Mp; Papa, G; Antimi, M; Gobbi, Pg; Porcellini, A; Rizzoli, V; Resegotti, L; Levis, A; Deriu, L; Chiericini, A; Ciccone, F; Fanin, R; Castoldi, G; Scapoli, Gl; Liso, V; Chisesi, T; Rancan, L; Amurri, B.
Alternating Nilotinib 400 mg twice daily and Imatinib 400 mg once daily as Frontline Treatment of Ph+ Chronic Myeloid Leukemia. A Phase 2 Multicentric Study of the GIMEMA CML Working Party
2011-01-01 Castagnetti, Fausto; Rosti, Gianantonio; Breccia, Massimo; Gozzini, Antonella; Stagno, Fabio; Cambrin, Giovanna Rege; Pierri, Ivana; Luciano, Luigia; Specchia, Giorgina; Abruzzese, Elisabetta; Martino, Bruno; Capucci, Adele; Bocchia, Monica; Cavazzini, Francesco; Tiribelli, Mario; Gugliotta, Gabriele; Palandri, Francesca; Durante, Sandra; Soverini, Simona; Testoni, Nicoletta; Pane, Fabrizio; Saglio, Giuseppe; Alimena, Giuliana; Martinelli, Giovanni; Baccara, Michele
An open-label, multicenter, expanded access study assessing the safety and efficacy of oral ruxolitinib administered to patients with primary myelofibrosis (PMF), post-polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF)
2012-01-01 le Coutre, Pd; Gisslinger, H; Zachee, P; Gupta, V; Perez, Jr; Schenk, N; Vutukuru, S; Garcia Hernandez, C; Tavares, R; Bocchia, Monica; Niederwieser, D.
Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
1994-01-01 Pileri, S; Bocchia, Monica; Baroni, Cd; Martelli, M; Falini, B; Sabattini, E; Gherlinzoni, F; Amadori, S; Poggi, S; Mazza, P.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin | 1-gen-2020 | Gozzetti, Alessandro; Sammartano, Vincenzo; Bacchiarri, Francesca; Raspadori, Donatella; Bocchia, Monica | - | |
| A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma | 1-gen-2023 | Sammartano, Vincenzo; Santoni, Adele; Zappone, Elisabetta; Calzoni, Paola; Fineschi, Daniela; Franceschini, Eleonora; Caroni, Federico; Sicuranza, Anna; Bocchia, Monica; Puccetti, Luca | - | |
| A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia. | 1-gen-2004 | Gozzetti, A; Tozzuoli, D; Crupi, R; Bocchia, Monica; Mazzotta, S; Raspadori, D; Lauria, Francesco | - | |
| A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): A case report. | 1-gen-2011 | Gozzetti, A; Cerase, A; Crupi, R; Raspadori, D; Defina, M; Bocchia, Monica; Lauria, Francesco | - | |
| A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2 | 1-gen-2010 | Gozzetti, A; Crupi, R; Rondoni, M; Defina, M; Bocchia, Monica; Pietrini, A; Raspadori, D; Lauria, Francesco | - | |
| A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? | 1-gen-2021 | Puccetti, Luca; Bacchiarri, Francesca; Calzoni, Paola; Santoni, Adele; Bocchia, Monica | - | |
| A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis | 1-gen-2021 | Vanni, Francesca; Lopresti, Ludovica; Zurli, Vanessa; Kabanova, Anna; Cattaneo, Francesca; Sicuranza, Anna; Gozzetti, Alessandro; Gemma, Sandra; Zisterer, Daniela M; Bocchia, Monica; Campiani, Giuseppe; Baldari, Cosima T; Butini, Stefania; Ulivieri, Cristina | - | |
| A novel t(6;7)(p24;q21) in a chronic myelocytic leuckemia in complete cytogenetic remission after therapy with imatinib mesylate. | 1-gen-2004 | Gozzetti, A; Tozzuoli, D; Crupi, R; Fanelli, A; Gentili, S; Bocchia, Monica; Mazzotta, S; Raspadori, D; Lauria, F. | - | |
| A P210-derived multipeptide vaccine (CMLVAX100) induces reduction of “stable” minimal residual disease in chronic myeloid leukemia (CML) patients during treatment with Imatinib or alpha-Interferon | 1-gen-2003 | Bocchia, Monica; Gentili, S; Abruzzese, E; Fanelli, A; Iuliano, F; Tabilio, A; Forconi, Francesco; Gozzetti, A; Raspadori, D; Amabile, M; Lauria, Francesco | - | |
| A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation | 1-gen-2020 | Dragani, Matteo; Rege Cambrin, Giovanna; Berchialla, Paola; Dogliotti, Irene; Rosti, Gianantonio; Castagnetti, Fausto; Capodanno, Isabella; Martino, Bruno; Cerrano, Marco; Ferrero, Dario; Gambacorti-Passerini, Carlo; Crugnola, Monica; Elena, Chiara; Breccia, Massimo; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Gozzini, Antonella; Bocchia, Monica; Lunghi, Francesca; Cedrone, Michele; Sgherza, Nicola; Luciano, Luigia; Russo, Sabina; Santoro, Marco; Giai, Valentina; Caocci, Giovanni; Levato, Luciano; Abruzzese, Elisabetta; Sora, Federica; Saglio, Giuseppe; Fava, Carmen | - | |
| A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA: RETROSPECTIVE ANALYSIS OF 530 PATIENTS. | 1-gen-2011 | Malagola, M; Skert, C; Vignetti, M; Piciocchi, A; G., Martinelli; Alimena, G; Mecucci, C; Testoni, N; Iacobucci, I; Clavio, M; Gobbi, M; Candoni, M; Damiani, D; Bocchia, Monica; Lauria, F; Zaccaria, A; Mazza, P; Visani, G; Peli, A; Colombi, C; Cancelli, V; Mancini, M; Fo, R; Martelli, M; Cantore, N; Raimondo, Fd; Petrini, M; DE FABRITIIS, P; Fioritoni, G; Nobile, F; Fabbiano, F; Specchia, G; Baccarani, G; LO COCO, F; Amadori, S; Mandelli, F; AND RUSSO, D. | - | |
| A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation | 1-gen-2016 | Mazzei, MARIA ANTONIETTA; Bettini, Gloria; Pozzessere, Chiara; Guerrini, Susanna; Defina, Marzia; Ambrosio, MARIA RAFFAELLA; Aprile, Lara; Bocchia, Monica; Volterrani, Luca | - | |
| ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: A study by the GIMEMA working party on chronic myeloid leukemia | 1-gen-2005 | Soverini, Simona; Martinelli, Giovanni; Rosti, Gianantonio; Bassi, Simona; Amabile, Marilina; Poerio, Angela; Giannini, Barbara; Trabacchi, Elena; Castagnetti, Fausto; Testoni, Nicoletta; Luatti, Simona; De Vivo, Antonio; Cilloni, Daniela; Izzo, Barbara; Fava, Milena; Abruzzese, Elisabetta; Alberti, Daniele; Pane, Fabrizio; Saglio, Giuseppe; Baccarani, Michele; GIMEMA CML Working, Party; Bocchia, Monica | - | |
| Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients | 1-gen-2006 | Iacobucci, Ilaria; Saglio, Giuseppe; Rosti, Gianantonio; Testoni, Nicoletta; Pane, Fabrizio; Amabile, Marilina; Poerio, Angela; Soverini, Simona; Bassi, Simona; Cilloni, Daniela; Bassan, Renato; Breccia, Massimo; Lauria, Francesco; Izzo, Barbara; Merante, Serena; Frassoni, Francesco; Paolini, Stefania; Montefusco, Enrico; Baccarani, Michele; Martinelli, Giovanni; GIMEMA CML Working, Party; Bocchia, Monica | - | |
| Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis | 1-gen-2012 | Luatti, Simona; Castagnetti, Fausto; Marzocchi, Giulia; Baldazzi, Carmen; Gugliotta, Gabriele; Iacobucci, Ilaria; Specchia, Giorgina; Zanatta, Lucia; Rege Cambrin, Giovanna; Mancini, Marco; Abruzzese, Elisabetta; Zaccaria, Alfonso; Grimoldi, Maria Grazia; Gozzetti, Alessandro; Ameli, Gaia; Capucci, Maria Adele; Palka, Giandomenico; Bernasconi, Paolo; Palandri, Francesca; Pane, Fabrizio; Saglio, Giuseppe; Martinelli, Giovanni; Rosti, Gianantonio; Baccarani, Michele; Testoni, Nicoletta; GIMEMA CML Working, Party; Bocchia, Monica | - | |
| Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients | 1-gen-2015 | Breccia, Massimo; Efficace, Fabio; Sica, Simona; Abruzzese, Elisabetta; Cedrone, Michele; Turri, Diamante; Gobbi, Marco; Carella, Angelo Michele; Gozzini, Antonella; Usala, Emilio; Cavazzini, Francesco; Danise, Paolo; Tiribelli, Mario; Binotto, Gianni; Pregno, Patrizia; Bocchia, Monica; Gaidano, Gianluca; Crugnola, Monica; Bonifacio, Massimiliano; Avanzini, Paolo; Celesti, Francesca; Guella, Anna; Martino, Bruno; Annunziata, Mario; Luciano, Luigiana; Stagno, Fabio; Vallisa, Daniele; Pungolino, Esther; Iurlo, Alessandra; Rambaldi, Alessandro; Nardiello, Ida; Orlandi, Esther; Gambacorti Passerini, Carlo; Alimena, Giuliana | - | |
| Alpha-2b recombinant interferon (Intron) in Hodgkins' lymphoma: Therapeutic perspective. | 1-gen-1990 | Mazza, P; Tura, S; Bocchia, Monica; Zinzani, Pl; Gherlinzoni, F; Mandelli, F; Anselmo, Mp; Papa, G; Antimi, M; Gobbi, Pg; Porcellini, A; Rizzoli, V; Resegotti, L; Levis, A; Deriu, L; Chiericini, A; Ciccone, F; Fanin, R; Castoldi, G; Scapoli, Gl; Liso, V; Chisesi, T; Rancan, L; Amurri, B. | - | |
| Alternating Nilotinib 400 mg twice daily and Imatinib 400 mg once daily as Frontline Treatment of Ph+ Chronic Myeloid Leukemia. A Phase 2 Multicentric Study of the GIMEMA CML Working Party | 1-gen-2011 | Castagnetti, Fausto; Rosti, Gianantonio; Breccia, Massimo; Gozzini, Antonella; Stagno, Fabio; Cambrin, Giovanna Rege; Pierri, Ivana; Luciano, Luigia; Specchia, Giorgina; Abruzzese, Elisabetta; Martino, Bruno; Capucci, Adele; Bocchia, Monica; Cavazzini, Francesco; Tiribelli, Mario; Gugliotta, Gabriele; Palandri, Francesca; Durante, Sandra; Soverini, Simona; Testoni, Nicoletta; Pane, Fabrizio; Saglio, Giuseppe; Alimena, Giuliana; Martinelli, Giovanni; Baccara, Michele | - | |
| An open-label, multicenter, expanded access study assessing the safety and efficacy of oral ruxolitinib administered to patients with primary myelofibrosis (PMF), post-polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF) | 1-gen-2012 | le Coutre, Pd; Gisslinger, H; Zachee, P; Gupta, V; Perez, Jr; Schenk, N; Vutukuru, S; Garcia Hernandez, C; Tavares, R; Bocchia, Monica; Niederwieser, D. | - | |
| Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases. | 1-gen-1994 | Pileri, S; Bocchia, Monica; Baroni, Cd; Martelli, M; Falini, B; Sabattini, E; Gherlinzoni, F; Amadori, S; Poggi, S; Mazza, P. | - |